Home » Ossio closes $38.5M Series C
October 17, 2022 By Sean Whooley
Orthopedic fixation exertion developer Ossio announced contiguous that it closed a $38.5 cardinal Series C financing round.
Growth equity steadfast MVM Partners led the funding. Current shareholders besides participated successful the round.
“We are delighted to person secured this level of involvement and committedness from specified an experienced and distinguished aesculapian exertion concern firm,” said Ossio CEO Brian Verrier. “The further backing volition alteration america to accelerate further adoption of Ossiofiber intelligent bony regeneration exertion by orthopedic and podiatric surgeons successful the United States.
“Specifically, we mean to usage these funds to fortify caller merchandise development, income unit expansion, diligent outreach and aesculapian education.”
Woburn, Massachusetts-based Ossio develops implants with its Ossiofiber intelligent bony regeneration technology. The institution designed it to lick the shortcomings of imperishable metallic hardware and conventional, resorbable and allograft implants.
The exertion combines mechanical spot and earthy bony healing successful a non-permanent implant. It is comprised of a proprietary mineral fibre matrix held unneurotic by a people degradable polymer. Ossio designed it with bio-integrative worldly properties that supply surgeons with a much biologically affable mode to reconstruct diligent stableness and mobility portion leaving thing imperishable behind.
Ossio developed its exertion for accelerated bony in-growth, regeneration and replacement. The institution said orthopedic surgeons implanted much than 10,000 Ossiofiber implants since its instauration successful 2019.
In transportation with the financing, MVM’s Dr. Stephen Reeders and Dr. Kevin Cheng joined Ossio’s committee of directors.
“We judge that Ossio’s caller bio-integrative exertion has the imaginable to alteration the orthopedic fixation market,” said Reeders. “We are excited to enactment the company’s ngo to amended diligent outcomes crossed a wide scope of procedures.”